Impaired quality of life in patients with intermittent atrial fibrillation

Nazlı, Cem; Eren, Nihan Kahya; Tülüce, Selcen Yakar; Yağız, İdil Gökçen Koçağra; Kiliçaslan, Barış; Kocabaş, Uğur

doi:10.5152/anatoljcardiol.2015.6144

Cited by 4 publications

(10 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 1 Although the symptoms of AF, including exercise intolerance, dyspnea, and fatigue, range from nonexistent to severe and differ among patients, the quality of life (QoL) of affected patients is usually impaired. 2 – 6 …”

Section: Introductionmentioning

confidence: 99%

“…QoL in patients with AF is reportedly associated with symptom severity scores, 6 the physical activity level, the New York Heart Association (NYHA) functional class, 11 and depression and anxiety symptoms. 12 , 13 Because possible pulmonary impairment has been reported, we believe that to examine QoL, patients with AF should be assessed in a comprehensive manner that includes assessment of both pulmonary function and respiratory muscle strength.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Relationship of respiratory muscle strength, pulmonary function, and functional capacity with quality of life in patients with atrial fibrillation

et al. 2017

View full text Add to dashboard Cite

ObjectiveTo examine the relationship of pulmonary parameters and functional capacity with quality of life (QoL) in patients with atrial fibrillation (AF).MethodsThirty-six patients with chronic AF were included in this cross-sectional study. QoL was assessed with the Medical Outcomes Survey 36-item Short Form (SF-36) and Minnesota Living with Heart Failure Questionnaire (MLHFQ). Respiratory muscle strength and pulmonary function were also measured. Functional capacity was assessed with the 6-min walk test (6MWT). The Borg CR10 Scale was used to determine the resting dyspnea and fatigue levels.ResultsThe SF-36 physical component summary score was correlated with the maximum inspiratory pressure (r = 0.517), maximum expiratory pressure (r = 0.391), 6MWT distance (r = 0.542), resting Borg dyspnea score (r = −0.692), and resting Borg fatigue score (r = −0.727). The MLHFQ total score was correlated with the maximum inspiratory pressure (r = −0.542), maximum expiratory pressure (r = −0.384), 6MWT distance (r = −0.535), resting Borg dyspnea score (r = 0.641), and resting Borg fatigue score (r = 0.703). The resting Borg fatigue score was the significant independent predictor of the SF-36 physical component score and the MLHFQ total score.ConclusionRespiratory muscle strength, functional capacity measured with the 6MWT, and resting symptoms including dyspnea and fatigue may have an impact on QoL in patients with AF.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Relationship of respiratory muscle strength, pulmonary function, and functional capacity with quality of life in patients with atrial fibrillation

et al. 2017

View full text Add to dashboard Cite

show abstract

“…30 The symptoms of AF disrupt daily life and range from mild to debilitating. 5 The frequency and severity of symptoms varies from patient to patient, and within a patient, and symptoms can fluctuate widely over time. These factors contribute to challenges in clinical decision-making in management of treatment.…”

Section: Symptoms Of Atrial Fibrillationmentioning

confidence: 99%

“…Patients with AF have an increased risk of life-threatening complications and other diseases, and AF also increases the risk for heart failure 5.0-fold, stroke 2.4-fold, and mortality 2.0-fold. 1 Furthermore, AF worsens quality of life (QoL) for patients and caregivers, [2][3][4][5][6][7] increasingly places a critical financial burden on healthcare systems, and is rapidly becoming one of the world's most significant health issues.…”

Section: Introductionmentioning

confidence: 99%

A Review of the Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic across Europe

et al. 2019

View full text Add to dashboard Cite

Atrial fibrillation (AF), the most common form of arrhythmia, is fast becoming one of the world’s most significant health issues. It is well established that AF increases the risk of mortality, and is associated with significant morbidity, including an increased risk of stroke. AF also worsens quality of life for patients, which can also be a burden for caregivers. As a result of Europe’s ageing population, the prevalence of AF is expected to rise substantially in the future. With more patients expected to be affected by AF, rates for AF-related strokes, hospitalisations, and doctor visits are also expected to rise, ultimately raising healthcare system costs across Europe. It is estimated that up to 2.6% of total annual healthcare expenditure is associated with AF in European countries. The high cost of AF is largely attributable to hospitalisations and complications such as stroke, i.e., in 2015, stroke was estimated to cost €45 billion a year in the European Union (EU). The purpose of this review is to highlight the current scale and growing burden of this new millennium epidemic in Europe. This review aims to foster a greater awareness and understanding of the magnitude of the clinical, patient, and economic burden of AF. An understanding of the burden of AF is imperative for directing care pathway management and healthcare policies that can help alleviate the burden of AF experienced by patients, caregivers, and healthcare systems in Europe.

show abstract

“…2,7 The symptoms of AF disrupt daily life and range from mild to debilitating. 9 Atrial fibrillation increases the risk of heart failure (5-fold risk), stroke (2.4-fold risk), and mortality (2-fold risk); 10 however, the seriousness of AF is critically misunderstood and 45% of AF patients are unaware that AF is a life-threatening condition. 11 Patients who do not experience symptoms of AF may be at greater risk of complications and disease severity due to lack of treatment.…”

Section: Overview Of Atrial Fibrillation Managementmentioning

confidence: 99%

Management of Atrial Fibrillation in Europe: Current Care Pathways and the Clinical Impact of Antiarrhythmic Drugs and Catheter Ablation

et al. 2019

View full text Add to dashboard Cite

Atrial fibrillation (AF), the most common form of arrhythmia, increases the risk of heart failure, stroke, and death. Management of AF focusses on effectively and safely controlling irregular heart rhythm, improving symptoms, and reducing complications. Early treatment of AF is important as it may improve patient life expectancy and quality of life (QoL). Current European guidelines recommend an integrated approach to AF management that involves shared decision making between patients and multidisciplinary teams of healthcare professionals to improve access to care and patient compliance. Treatment options include the use of anticoagulants, cardioversion, rate control therapies, and rhythm control therapies. Over the long term, rhythm control strategies that include antiarrhythmic drugs (AAD) and catheter ablation are the most common methods for controlling AF. The objective of this review is to highlight current European AF care pathway management recommendations and to examine the clinical, economic, and patient impact of different treatment options, including AAD and catheter ablation. While AAD have been shown to improve QoL and are affordable in the short term, treatment is moderately effective, associated with significant side effects, and can be costly long term. Catheter ablation is a highly effective therapy choice that improves patient wellbeing and is associated with a low rate of ablation-related complications. Compared to drug therapy, catheter ablation provides a significant reduction in AF burden, reduces rates of recurrence, provides a greater improvement in QoL, and facilitates long-term cost savings.

show abstract

Impaired quality of life in patients with intermittent atrial fibrillation

Cited by 4 publications

References 31 publications

Relationship of respiratory muscle strength, pulmonary function, and functional capacity with quality of life in patients with atrial fibrillation

Relationship of respiratory muscle strength, pulmonary function, and functional capacity with quality of life in patients with atrial fibrillation

A Review of the Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic across Europe

Management of Atrial Fibrillation in Europe: Current Care Pathways and the Clinical Impact of Antiarrhythmic Drugs and Catheter Ablation

Contact Info

Product

Resources

About